| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00436475 |
| P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
| phase II clinical trial | Q42824440 | ||
| P17 | country | United States of America | Q30 |
| P582 | end time | 2009-11-01 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| P1050 | medical condition | diabetes | Q12206 |
| metabolic syndrome | Q657193 | ||
| glucose intolerance | Q2661464 | ||
| P2899 | minimum age | 40 | |
| P1132 | number of participants | 112 | |
| P4844 | research intervention | calcium carbonate | Q23767 |
| calcium oxalate | Q412399 | ||
| (5R)-24,25-Dihydroxyvitamin D | Q27161510 | ||
| P1813 | short name | CaDDM | |
| P580 | start time | 2007-09-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes |